pembrolizumab
merck
['pembro']
adding pembrolizumab to frontline chemotherapy improves overall survival in patients with advanced biliary tract cancer, a phase 3 trial presented at aacr 2023 suggests. #aacr23 
https://t.co/bi63MIVP5D is a resource offering oncology health care professionals practical information about the changing clinical landscape.